FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma

Conclusions: High expression of FOSL1 is an independent risk factor of HCC predicting unfavorable prognosis, indicating that FOSL1 detection could stratify patients with high risk, and anti-FOSL1 therapy may be a promising way to treat HCC.
Source: The Saudi Journal of Gastroenterology - Category: Gastroenterology Authors: Source Type: research